The nonprofit organization presents evidence of strategic thinking and goal setting through sharing their most important strategic goals.
Goal One: Make islet transplantation available to those in need with the limited organs available and using immunosuppression to prevent both rejection and recurrence of autoimmune type-1 diabetes.
Goal Type: Grow, expand, scale or increase access to the existing programs and services.
Goal Two: Search for an unlimited source of glucose sensitive, insulin secreting cells.
Goal Type: Grow, expand, scale or increase access to the existing programs and services.
Goal Three: Provide technology to shield transplanted islet cells from the assaults of the immune system to avoid the need for the use of harmful immunosuppressive medications.
Goal Type: Grow, expand, scale or increase access to the existing programs and services.